Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2000
08/30/2000CN1265035A Method for inhibiting bone resorption
08/30/2000CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides
08/30/2000CN1055848C Traditional Chinese patent drugs for curing gastrointestinal tract disease and gynopathy
08/29/2000US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/24/2000WO2000049144A2 Pyk2 binding proteins
08/24/2000WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders
08/24/2000WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
08/24/2000WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/23/2000EP1029869A1 Endothelin converting enzyme inhibitors
08/23/2000EP1029541A1 Therapeutic or prophylactic agent for glomerulopathy
08/23/2000EP1029540A2 Use of droloxifene for the treatment of cardiovascular diseases
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000EP0640072B1 Derivatives of pyridine as hydroxylase and lyase inhibitors
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1264365A 3-benzoylindole derivatives and drugs containing the same
08/23/2000CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
08/23/2000CN1055624C Scorpion-and-ant oral liquid and its preparation method
08/23/2000CN1055620C Use of hydriodic acid as an aphrodisiac
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6106864 Pharmaceutical formulations containing darifenacin
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2165992C Disulphides
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
08/17/2000WO2000047215A2 Methods for anti-tumor therapy
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
08/16/2000EP1027325A2 Lipophilic diesters of chelating agents
08/16/2000EP1027053A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
08/16/2000EP1027048A2 Selective cyclooxygenase-2 inhibitors against premature labor
08/16/2000EP1027047A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
08/16/2000EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity
08/16/2000CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
08/16/2000CN1263466A Solutions containing azasteroids
08/16/2000CN1263461A Pharmaceutical composition
08/16/2000CN1262939A Medicine for external use for curing chronic prostatitis
08/16/2000CN1262937A Medicinal composition for curing and preventing urinary calculus
08/16/2000CN1055480C Substitution analogues of magainin peptides
08/16/2000CN1055409C Medicine for curing complicated urinary tract infection
08/16/2000CN1055391C Use of substituted aromatic steroids control fertility and pharmaceutical composition thereof
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103747 Substituted imidazole derivative used as antagonists against muscarinic acetylcholine receptor on smooth muscles, treats dysuria
08/15/2000US6103738 Quinoline and quinazoline compounds useful in therapy
08/15/2000US6103732 Endothelin receptor inhibitors; hypotensive agents, cardiotonic agents; acute myocardial infarct, pulmonary hypertension, raynaud's syndrome, atherosclerosis; asthma; cardiovascular disorders
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/10/2000WO2000046235A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
08/10/2000WO2000046228A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000WO2000046227A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000WO2000046225A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000WO2000046224A2 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046220A1 Triazole and tetrazole derivatives, and their therapeutic use
08/10/2000WO2000046219A1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
08/10/2000WO2000045809A1 L-arginine based formulations for treating diseases and methods of using same
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 562